IconOVir Bio

Operator of a preclinical-stage biotechnology company intended to improve the treatment of patients with cancer. The company's proprietary oncolytic virus platform is designed to address key limitatio...

Healthcare

New York, NY, United States

Founded 2018

12 employees

Website

Valuation

Share Price

N/A

Total Raised

$97.2M

Last Round

N/A

Investors

+8 other investors

View all 8 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock IconOVir Bio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required